These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 9622888

  • 1. [Standards, perspectives and limits of conservative therapy of chronic inflammatory bowel diseases].
    Rogler G, Andus T, Schölmerich J.
    Zentralbl Chir; 1998; 123(4):316-24. PubMed ID: 9622888
    [Abstract] [Full Text] [Related]

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 3. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
    Seibold F, Wagner AC, Göke B.
    Schweiz Med Wochenschr; 2000 Feb 19; 130(7):222-32. PubMed ID: 10719713
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C.
    Ther Umsch; 1997 Nov 19; 54(11):649-53. PubMed ID: 9454368
    [Abstract] [Full Text] [Related]

  • 5. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C, Gasché C, Reinisch W, Moser G, Novacek G, Tillinger W, Vogelsang H, Gangl A.
    Wien Klin Wochenschr; 1998 Sep 04; 110(16):579-84. PubMed ID: 9782579
    [Abstract] [Full Text] [Related]

  • 6. [Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
    Dejaco C, Haas T, Kirchgatterer A, Miehsler W, Wenzl H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W, Tilg H.
    Z Gastroenterol; 2006 Jun 04; 44(6):525-38; discussion 539. PubMed ID: 16773519
    [Abstract] [Full Text] [Related]

  • 7. [Therapeutic principles for chronic inflammatory bowel disease].
    Binder V, Munkholm P.
    Ugeskr Laeger; 2001 Jan 01; 163(1):16-21. PubMed ID: 11586666
    [Abstract] [Full Text] [Related]

  • 8. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct 01; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 9. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A, Halter F.
    Ther Umsch; 1993 Feb 01; 50(2):94-9. PubMed ID: 8096092
    [Abstract] [Full Text] [Related]

  • 10. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
    Hibi T, Inoue N, Ogata H, Naganuma M.
    J Gastroenterol; 2003 Mar 01; 38 Suppl 15():36-42. PubMed ID: 12698869
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of chronic inflammatory bowel diseases].
    Lémann M.
    Bull Acad Natl Med; 2007 Jun 01; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibody therapy of inflammatory bowel disease.
    van Deventer SJ, Camoglio L.
    Aliment Pharmacol Ther; 1996 Jun 01; 10 Suppl 2():107-11; discussion 112. PubMed ID: 8899109
    [Abstract] [Full Text] [Related]

  • 13. [New therapeutic possibilities in chronic inflammatory bowel diseases].
    Zeitz M.
    Praxis (Bern 1994); 1997 Jun 18; 86(25-26):1071-4. PubMed ID: 9289806
    [Abstract] [Full Text] [Related]

  • 14. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
    Saniabadi AR, Hanai H, Suzuki Y, Ohmori T, Sawada K, Yoshimura N, Saito Y, Takeda Y, Umemura K, Kondo K, Ikeda Y, Fukunaga K, Nakashima M, Beretta A, Bjarnason I, Lofberg R.
    J Clin Apher; 2005 Oct 18; 20(3):171-84. PubMed ID: 15892107
    [Abstract] [Full Text] [Related]

  • 15. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
    Domènech E, Hinojosa J, Esteve-Comas M, Gomollón F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA, Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU).
    Aliment Pharmacol Ther; 2004 Dec 18; 20(11-12):1347-52. PubMed ID: 15606397
    [Abstract] [Full Text] [Related]

  • 16. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
    Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA.
    Am J Gastroenterol; 2008 May 18; 103(5):1203-9. PubMed ID: 18422816
    [Abstract] [Full Text] [Related]

  • 17. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece.
    Christodoulou D, Katsanos K, Baltayannis G, Tzabouras N, Tsianos EV.
    Hepatogastroenterology; 2003 May 18; 50(52):1021-4. PubMed ID: 12845970
    [Abstract] [Full Text] [Related]

  • 18. Management of inflammatory bowel disease.
    Botoman VA, Bonner GF, Botoman DA.
    Am Fam Physician; 1998 Jan 01; 57(1):57-68, 71-2. PubMed ID: 9447214
    [Abstract] [Full Text] [Related]

  • 19. Review article: systemic and topical steroids in inflammatory bowel disease.
    Schölmerich J.
    Aliment Pharmacol Ther; 2004 Oct 01; 20 Suppl 4():66-74. PubMed ID: 15352897
    [Abstract] [Full Text] [Related]

  • 20. [The conservative treatment of nonspecific inflammatory bowel diseases].
    Wojtuń S, Gil J, Chojnacki J, Wichan P.
    Pol Merkur Lekarski; 2004 Oct 01; 17 Suppl 1():35-9. PubMed ID: 15603344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.